New Drug ApprovalAbbVie’s VENCLEXTA Taps AZ’s Acalabrutinib for FDA’s Firs... AbbVie’s VENCLEXTA Taps AZ’s Acalabrutinib for FDA’s Firs... Read Post »
New Drug ApprovalEuropean Commission Grants Conditional Approval for ANKTIVA® in BCG-Unresp... European Commission Grants Conditional Approval for ANKTIVA® in BCG-Unresp... Read Post »
Health TidingsBoehringer Ingelheim Teams Up with NIPER Raebareli for Pharma Research Boos... Boehringer Ingelheim Teams Up with NIPER Raebareli for Pharma Research Boos... Read Post »
Clinical TrailsViiV Healthcare’s Cabenuva Demonstrates Superior Efficacy in LATITUDE... ViiV Healthcare’s Cabenuva Demonstrates Superior Efficacy in LATITUDE... Read Post »
Health TidingsFDA Grants Priority Review to Garetosmab for Rare Bone Disorder FOP FDA Grants Priority Review to Garetosmab for Rare Bone Disorder FOP Read Post »
Clinical TrailsMerck’s ENFLONSIA Shows Promising Safety in Second RSV Season for Hig... Merck’s ENFLONSIA Shows Promising Safety in Second RSV Season for Hig... Read Post »
Health Tidings Policy & AcquisitionsNovartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Novartis Licenses UNP’s Macrocyclic Peptides in $1.8B CVD Collaborati... Read Post »
Clinical TrailsPfizer Advances BRAFTOVI in Colorectal Cancer with New BREAKWATER Results Pfizer Advances BRAFTOVI in Colorectal Cancer with New BREAKWATER Results Read Post »
Clinical TrailsNovartis’ Remibrutinib Shows Promise in Chronic Inducible Urticaria Novartis’ Remibrutinib Shows Promise in Chronic Inducible Urticaria Read Post »
Health TidingsJanux Therapeutics Dosed First Patient in JANX011 Study Janux Therapeutics Dosed First Patient in JANX011 Study Read Post »
Health TidingsRTF Resolved: Moderna’s Vaccine mRNA-1010 Advances to FDA Review RTF Resolved: Moderna’s Vaccine mRNA-1010 Advances to FDA Review Read Post »
Health TidingsFDA Accepts BMS’s NDA for Iberdomide in RRMM FDA Accepts BMS’s NDA for Iberdomide in RRMM Read Post »
Health TidingsEli Lilly’s TOGETHER-PsO Trial: Taltz Plus Zepbound Delivers Superior... Eli Lilly’s TOGETHER-PsO Trial: Taltz Plus Zepbound Delivers Superior... Read Post »
Health TidingsCompass Pathways Achieves Breakthrough in Phase 3 Trial for Psilocybin-Base... Compass Pathways Achieves Breakthrough in Phase 3 Trial for Psilocybin-Base... Read Post »
New Drug ApprovalFDA Approves Simplified Monthly Dosing for RYBREVANT FASPRO™ in EGFR-Muta... FDA Approves Simplified Monthly Dosing for RYBREVANT FASPRO™ in EGFR-Muta... Read Post »
Clinical TrailsViiV Healthcare Highlights Lotivibart and Cabotegravir LA Findings at CROI ... ViiV Healthcare Highlights Lotivibart and Cabotegravir LA Findings at CROI ... Read Post »
Health TidingsGSK RSV Vaccine Shows 75.6% Effectiveness Against Hospitalizations in Real-... GSK RSV Vaccine Shows 75.6% Effectiveness Against Hospitalizations in Real-... Read Post »
Clinical TrailsOcular Therapeutix’s AXPAXLI Achieves Superiority in Wet AMD Phase 3 ... Ocular Therapeutix’s AXPAXLI Achieves Superiority in Wet AMD Phase 3 ... Read Post »
New Drug ApprovalGSK’s Exdensur Gains EU Approval for Severe Asthma and CRSwNP GSK’s Exdensur Gains EU Approval for Severe Asthma and CRSwNP Read Post »
Clinical TrailsSanofi and Teva Report Durable Duvakitug Efficacy at 44 Weeks in UC/CD: REL... Sanofi and Teva Report Durable Duvakitug Efficacy at 44 Weeks in UC/CD: REL... Read Post »
Health Tidings Policy & AcquisitionsKidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Kidswell Bio and Treehill Launch Kidswell USA to Advance Cell Therapy for C... Read Post »
Clinical TrailsUltragenyx Reports Long-Term Success of UX111 Gene Therapy for Sanfilippo S... Ultragenyx Reports Long-Term Success of UX111 Gene Therapy for Sanfilippo S... Read Post »
Drugs Safety AlertValneva’s IXCHIQ Gets UK Safety Restrictions for Older Adults Valneva’s IXCHIQ Gets UK Safety Restrictions for Older Adults Read Post »
FoodDaily Coffee and Tea Habits Associated With Reduced Dementia Risk Daily Coffee and Tea Habits Associated With Reduced Dementia Risk Read Post »
Health TidingsOno Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Ono Pharmaceutical’s Tirabrutinib NDA Accepted by FDA for R/R PCNSL Read Post »
Health TidingsLilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Lilly’s Retevmo Improves Event-Free Survival in Early RET+ NSCLC Read Post »
Health TidingsNeedle-Free neffy: Launches in Australia for Anaphylaxis Needle-Free neffy: Launches in Australia for Anaphylaxis Read Post »
Health TidingsEisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Eisai Secures Orphan Drug Designation in Japan for E2086 in Narcolepsy Read Post »
Clinical TrailsRoche’s Gazyva/Gazyvaro Hits pMN Remission in Phase III MAJESTY Trial Roche’s Gazyva/Gazyvaro Hits pMN Remission in Phase III MAJESTY Trial Read Post »
Clinical TrailsSanofi’s NIRSE-GAL Study Shows Beyfortus Protect Infants Beyond First RSV... Sanofi’s NIRSE-GAL Study Shows Beyfortus Protect Infants Beyond First RSV... Read Post »
Drugs Safety AlertFDA Approves Genzyme’s Thymoglobulin® and Gamida Cell’s Omisirge L... FDA Approves Genzyme’s Thymoglobulin® and Gamida Cell’s Omisirge L... Read Post »
Drugs Safety AlertLevamisole to be Withdrawn from EU Market Over Leukoencephalopathy Risk Levamisole to be Withdrawn from EU Market Over Leukoencephalopathy Risk Read Post »
Drugs Safety AlertWhat’s New in the FDA’s iPLEDGE REMS Update for Isotretinoin What’s New in the FDA’s iPLEDGE REMS Update for Isotretinoin Read Post »
Health TidingsOtsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Otsuka’s REXULTI Added to Japan’s Disaster Essential Medicines List Read Post »
Health TidingsDisc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Disc Medicine Gets FDA CRL for Bitopertin, Eyes APOLLO Trial Read Post »
Clinical TrailsNovartis Vanrafia® Slows IgAN Kidney Decline Novartis Vanrafia® Slows IgAN Kidney Decline Read Post »
New Drug ApprovalAmgen’s UPLIZNA® Approved for gMG in EU Amgen’s UPLIZNA® Approved for gMG in EU Read Post »
Clinical TrailsAstraZeneca Breztri Boosts FEV1 in Asthma Trials AstraZeneca Breztri Boosts FEV1 in Asthma Trials Read Post »
Clinical TrailsLundbeck Reports Positive Phase IIb Results for Bocunebart in Migraine Lundbeck Reports Positive Phase IIb Results for Bocunebart in Migraine Read Post »
Health TidingsPTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback PTC Pulls Ataluren NDA for nmDMD After FDA Review Feedback Read Post »
Health TidingsINmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB INmune Bio Files MHRA Pre-Submission for CORDStrom in RDEB Read Post »
Clinical TrailsINmune Bio Advances XPro1595 to FDA-Aligned AD Trial INmune Bio Advances XPro1595 to FDA-Aligned AD Trial Read Post »
Health TidingsNovo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Novo Nordisk Targets Access and Flexibility with Planned Wegovy Vials Read Post »
Drugs Safety AlertFDA Removes Boxed Warning from Menopausal Hormone Therapy Labels FDA Removes Boxed Warning from Menopausal Hormone Therapy Labels Read Post »
Clinical TrailsBridgeBio’s Infigratinib Achieves Breakthrough Phase 3 Results in Ach... BridgeBio’s Infigratinib Achieves Breakthrough Phase 3 Results in Ach... Read Post »
Health TidingsOutlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Outlook Therapeutics Seeks FDA Type A Meeting Following CRL for LYTENAVA™... Read Post »
Clinical TrailsINSIGHTT Trial Approved: Sarepta’s HD Therapy Advances INSIGHTT Trial Approved: Sarepta’s HD Therapy Advances Read Post »
Health TidingsREGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... REGENXBIO Unveils 2026 Pipeline Catalysts with Strong 18-Month DMD Trial Da... Read Post »
Health TidingsDewpoint MYC Condensate Modulator Hits DC Stage Dewpoint MYC Condensate Modulator Hits DC Stage Read Post »
